Profusa, Inc. (PFSA): Net Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$35.82M

Year ended 2025-12-31

2022-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$35.82M	n/m	2026-04-15, From 2025-01-01
2024-12-31	-$9.23M	n/c	2026-04-15, From 2024-01-01
2023-12-31	$1.16M	-83.8%	2025-03-31, From 2023-01-01
2022-12-31	$7.17M	n/a	2024-02-26, From 2022-01-01

Net Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Profusa, Inc. (PFSA)	2025-12-31	-$35.82M	n/m
Encision Inc (ECIA)	2025-03-31	-$220.2K	n/m
PetVivo Holdings, Inc. (PETV)	2026-03-31	-$10.47M	n/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)	2025-12-31	-$6.87M	n/m
QTREX Quantum Ltd. (QTEX)	2025-12-31	-$13.22M	n/m
HeartBeam, Inc. (BEATW)	2025-12-31	-$21.02M	n/m
Aethlon Medical Inc (AEMD)	2026-03-31	-$7.15M	n/m
Biotricity Inc. (BTCY)	2026-03-31	-$2.40M	n/m
QHSLab, Inc. (USAQ)	2025-12-31	$457.4K	n/m

Compare PFSA, ECIA, PETV, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗